Dr. Samer Al-Shurieki, MD
What this data tells you about Dr. Al-Shurieki
Dr. Samer Al-Shurieki is a gastroenterology in Pensacola, FL, with 20 years in practice. Based on federal Medicare data, Dr. Al-Shurieki performed 30,721 Medicare services across 1,667 unique beneficiaries.
Between the years covered by Open Payments, Dr. Al-Shurieki received a total of $5,951 from 25 pharmaceutical and/or device companies across 381 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gastroenterology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Al-Shurieki is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Vedolizumab infusion (Entyvio) | 24,900 | $17 | $37 |
| Infliximab infusion (Remicade) | 3,790 | $26 | $115 |
| Upper GI endoscopy with biopsy | 336 | $96 | $771 |
| Dilation of esophagus | 201 | $31 | $378 |
| Office visit, established patient (30-39 min) | 193 | $94 | $195 |
| Removal of polyps or growths of large bowel using a flexible endoscope with electrical cautery | 158 | $170 | $1,010 |
| Administration of chemotherapy into vein, 1 hour or less | 157 | $98 | $278 |
| Infusion, normal saline solution, 250 cc | 156 | $1 | $1 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 116 | $209 | $935 |
| Initial hospital admission, high complexity | 108 | $131 | $306 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 94 | $181 | $698 |
| Colonoscopy with biopsy | 92 | $103 | $897 |
| Hospital follow-up visit, high complexity | 92 | $93 | $157 |
| Administration of chemotherapy into vein, each additional hour | 74 | $22 | $61 |
| Office visit, established patient (20-29 min) | 55 | $63 | $137 |
| New patient office visit (45-59 min) | 38 | $109 | $247 |
| New patient office visit (30-44 min) | 30 | $63 | $162 |
| Initial hospital admission, moderate complexity | 29 | $100 | $212 |
| Diagnostic exam of large bowel using a flexible endoscope | 27 | $141 | $698 |
| Hospital follow-up visit, moderate complexity | 23 | $63 | $110 |
| Control of bleeding of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 20 | $144 | $1,344 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 19 | $88 | $603 |
| Incision of pancreatic outlet using a flexible endoscope | 13 | $47 | $1,058 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Al-Shurieki is a mixed practice specialist, with above-average Medicare volume (top 0% in FL), and low-engagement industry engagement, with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Al-Shurieki experienced with vedolizumab infusion (entyvio)?
Does Dr. Al-Shurieki receive payments from pharmaceutical companies?
How do Dr. Al-Shurieki's costs compare to other gastroenterologys in Pensacola?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology